Back to search

Article

Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down Syndrome

2018-03-05

Abstract excerpt

In Down syndrome (DS), the overall genetic imbalance caused by trisomy of chromosome 21 leads to a complex pleiotropic phenotype that involves a recognizable set of facial traits. Several studies have shown the potential of epigallocatechin-3-gallate (EGCG), a green tea flavanol, as a therapeutic tool for alleviating different developmental alterations associated with DS, such as cognitive impairment, skull dysmor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
afb0b057-e68c-56dc-8407-e65041d9ab75
DOI
10.1101/276493
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down SyndromeDOI 10.1101/276493
Select a neighboring publication to make it the new centre.